Skip to main content

UPDATE: Beckman Coulter to Distribute Xtrana s DNA Extraction Technology

NEW YORK, Jan 22 – Beckman Coulter has signed an agreement to distribute Biopool International- Xtrana's DNA extraction kits with its instrument systems, the companies announced Monday.

Beckman Coulter plans to sell the DNA extraction technology, used in life science research to extract DNA from whole blood, with machines such as the Biomek workstation before the middle of the year, according to Susan Stone, a marketing manager at Beckman Coulter.

As a result of the agreement, Beckman Coulter will have non-exclusive, worldwide rights to Xtrana’s proprietary Xtra Amp extraction kits. Neither company divulged the financial details of the arrangement.

The extraction technology utilizes a solid-phase extraction matrix, known as Xtra Bind, that requires no centrifugation or vacuum filtration. The result is a faster and cheaper process, because the Xtra Amp kits require no additional instrumentation, said Shannon Beard, vice president for technology development at Biopool Xtrana.

“In our case, the DNA physically binds to this crystalline matrix,” said Beard. “Then it just becomes a liquid handling procedure.”

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.